Relationship between serum amyloid A level and Tanis/SelS mRNA expression in skeletal muscle and adipose tissue from healthy and type 2 diabetic subjects
about
Identification and characterization of selenoprotein K: an antioxidant in cardiomyocytesSelenium and Metabolic Disorders: An Emphasis on Type 2 Diabetes RiskSelenium and diabetes--evidence from animal studiesThe role of the selenoprotein S (SELS) gene -105G>A promoter polymorphism in inflammatory bowel disease and regulation of SELS gene expression in intestinal inflammationGenetic variation in selenoprotein S influences inflammatory responseRegulation and function of selenoproteins in human diseaseExpression of the selenoprotein S (SELS) gene in subcutaneous adipose tissue and SELS genotype are associated with metabolic risk factors.Alternative transcripts and 3'UTR elements govern the incorporation of selenocysteine into selenoprotein SThe source of circulating selenoprotein S and its association with type 2 diabetes mellitus and atherosclerosis: a preliminary study.Dexamethasone-induced selenoprotein S degradation is required for adipogenesisEffects of selenoprotein S on oxidative injury in human endothelial cells.Selenium biochemistry and its role for human health.Molecular characterization and NF-κB-regulated transcription of selenoprotein S from the Bama mini-pig.Selenoprotein S: a therapeutic target for diabetes and macroangiopathy?Selenoprotein S is involved in maintenance and transport of multiprotein complexes.Changes in human adipose tissue gene expression during diet-induced weight loss.
P2860
Q24302087-C57AFA0F-C123-431D-A9F7-F65482C6B4BFQ26767204-89660130-8D17-4A0C-B345-2119E81C2531Q26821855-E5094367-FDEA-474E-96F1-1642ECA8D2F4Q28238475-F77AC451-692D-4435-9CBA-EE4E7BB559ADQ28277290-2CDDFF8D-6C1C-4124-8208-B7752F222B99Q34029071-D82AB87B-EC8D-45F0-A664-38B4FE80E44EQ34415355-3D9B94C6-9E3E-4576-AC1F-7A391BF276F8Q34685587-7F2C598C-D91B-410B-AC1D-F68C15F2FB1EQ36847380-72AD3989-E432-4F07-A795-D2032CB0AF49Q37002631-FC4C0431-73F4-414F-A727-8EAB3A93F3EAQ37539564-1B4C168C-4BCA-4F31-9FDF-9A2C5C80EA17Q38159453-6479D612-AB24-4322-B1FB-A65EA909403FQ39625990-77AB065D-C446-46BB-9DF6-615228C67E97Q41362272-AE22A4D8-04B0-4569-BD02-964F5FC4D3BAQ41576322-01569BD5-9865-41BB-BB6C-63D351036F6EQ47578306-60F22A41-B829-401B-B793-32340551B6CB
P2860
Relationship between serum amyloid A level and Tanis/SelS mRNA expression in skeletal muscle and adipose tissue from healthy and type 2 diabetic subjects
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Relationship between serum amy ...... y and type 2 diabetic subjects
@ast
Relationship between serum amy ...... y and type 2 diabetic subjects
@en
Relationship between serum amy ...... y and type 2 diabetic subjects
@nl
type
label
Relationship between serum amy ...... y and type 2 diabetic subjects
@ast
Relationship between serum amy ...... y and type 2 diabetic subjects
@en
Relationship between serum amy ...... y and type 2 diabetic subjects
@nl
prefLabel
Relationship between serum amy ...... y and type 2 diabetic subjects
@ast
Relationship between serum amy ...... y and type 2 diabetic subjects
@en
Relationship between serum amy ...... y and type 2 diabetic subjects
@nl
P2093
P3181
P1433
P1476
Relationship between serum amy ...... y and type 2 diabetic subjects
@en
P2093
Heikki A Koistinen
Hiroki Tsuchida
Håkan K R Karlsson
Staffan Lake
P304
P3181
P356
10.2337/DIABETES.53.6.1424
P407
P50
P577
2004-06-01T00:00:00Z